Barium sulphate microparticles are taken up by three different cell types: HeLa, THP-1, and hMSC
Source abstract
Abstract
Cytotoxicity and cellular uptake of spherical barium sulphate microparticles (diameter 1 µm) were studied with three different cell lines, i.e. THP-1 cells (monocytes; model for a phagocytosing cell line), HeLa cells (epithelial cells; model for a non-phagocytosing cell line), and human mesenchymal stem cells (hMSCs; model for non-phagocytosing primary cells). Barium sulphate is a chemically and biologically inert solid which allows to distinguish two different processes, e.g. the particle uptake and potential adverse biological reactions. Barium sulphate microparticles were surface-coated by carboxymethylcellulose (CMC) which gave the particles a negative charge. Fluorescence was added by conjugating 6-aminofluorescein to CMC. The cytotoxicity of these microparticles was studied by the MTT test and a live/dead assay. The uptake was visualized by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). The particle uptake mechanism was quantified by flow cytometry with different endocytosis inhibitors in THP-1 and HeLa cells. The microparticles were easily taken up by all cell types, mostly by phagocytosis and micropinocytosis, within a few hours. STATEMENT OF SIGNIFICANCE: The interaction of particles and cells is of primary importance in nanomedicine, drug delivery, and nanotoxicology. It is commonly assumed that cells take up only nanoparticles unless they are able to phagocytosis. Here, we demonstrate with chemically and biologically inert microparticles of barium sulphate that even non-phagocytosing cells like HeLa and hMSCs take up microparticles to a considerable degree. This has considerable implication in biomaterials science, e.g. in case of abrasive debris and particulate degradation products from implants like endoprostheses.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. Injectable composite systems based on microparticles in hydrogels for bioactive cargo controlled delivery10.3390/gels7030147 ↗
2. Injectable nanosilica-chitosan microparticles for bone regeneration applications10.1177/0885328217741523 ↗
3. Microfluidic fabrication of microparticles for biomedical applications10.1039/C7CS00263G ↗
4. Effects of microparticle size and Fc density on macrophage phagocytosis10.1371/journal.pone.0060989 ↗
5. Nanoparticle interactions with live cells: quantitative fluorescence microscopy of nanoparticle size effects10.3762/bjnano.5.248 ↗
6. Particle shape enhances specificity of antibody-displaying nanoparticles10.1073/pnas.1216893110 ↗
7. Quantitative particle–cell interaction: some basic physicochemical pitfalls10.1021/acs.langmuir.6b04629 ↗
8. Multiple internalization pathways of polyelectrolyte multilayer capsules into mammalian cells10.1021/nn306032k ↗
9. In vitro interaction of colloidal nanoparticles with mammalian cells: what have we learned thus far?10.3762/bjnano.5.161 ↗
10. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles10.2147/IJN.S36111 ↗
11. Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells10.1016/j.actbio.2013.02.034 ↗
12. Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells10.1002/smll.201201129 ↗
13. Diverse applications of nanomedicine10.1021/acsnano.6b06040 ↗
14. An updated review of the genotoxicity of respirable crystalline silica10.1186/s12989-018-0259-z ↗
15. The effect of short silica fibers (0.3μm 3.2μm) on macrophages10.1016/j.scitotenv.2020.144575 ↗
16. Particle toxicology and health - where are we?10.1186/s12989-019-0302-8 ↗
17. Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity10.1186/1476-069X-13-59 ↗
18. Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences10.1016/j.addr.2013.07.014 ↗
19. WHO/ILO work-related burden of disease and injury: protocol for systematic reviews of occupational exposure to dusts and/or fibres and of the effect of occupational exposure to dusts and/or fibres on pneumoconiosis10.1016/j.envint.2018.06.005 ↗
20. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases10.1080/10937404.2011.556051 ↗
21. A mechanistic review of silica-induced inhalation toxicity10.3109/08958378.2015.1066905 ↗
22. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles10.1289/ehp.7339 ↗
23. Dosimetry and toxicology of inhaled ultrafine particles10.1080/13547500902965617 ↗
24. Isolation and characterisation of wear debris surrounding failed total ankle replacements10.1016/j.actbio.2023.01.051 ↗
25. The pathobiology and pathology of aseptic implant failure10.1302/2046-3758.55.BJR-2016-0086 ↗
26. In vitro/in vivo assessment and mechanisms of toxicity of bioceramic materials and its wear particulates10.1039/c3ra44483j ↗
27. Emperor's new clothes: Is particle disease really infected particle disease?10.1002/jor.23292 ↗
28. Weight of polyethylene wear particles is similar in TKAs with oxidized zirconium and cobalt-chrome prostheses10.1007/s11999-009-1179-x ↗
29. Probing the influence of γ-sterilization on the oxidation, crystallization, sliding wear resistance, and cytocompatibility of chemically modified graphene-oxide-reinforced HDPE/UHMWPE nanocomposites and wear debris10.1021/acsbiomaterials.9b01327 ↗
30. Mixed material wear particle isolation from periprosthetic tissue surrounding total joint replacements10.1002/jbm.b.35076 ↗
31. Biokinetics and effects of barium sulfate nanoparticles, Part10.1186/s12989-014-0055-3 ↗
32. Barium sulfate micro- and nanoparticles as bioinert reference material in particle toxicology10.1080/17435390.2016.1235740 ↗
33. A systematic electron microscopic study on the uptake of barium sulphate nano-, submicro-, microparticles by bone marrow-derived phagocytosing cells10.1016/j.actbio.2018.09.026 ↗
34. Exploiting endocytosis for nanomedicines10.1101/cshperspect.a016980 ↗
35. Understanding nanoparticle cellular entry: a physicochemical perspective10.1016/j.cis.2015.01.007 ↗
36. Brief update on endocytosis of nanomedicines10.1016/j.addr.2019.08.004 ↗
37. Endocytosis at the nanoscale10.1039/c2cs15309b ↗
38. Nanocarriers' entry into the cell: relevance to drug delivery10.1007/s00018-009-0053-z ↗
39. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies10.1016/j.nantod.2011.02.003 ↗
40. Physical principles of nanoparticle cellular endocytosis10.1021/acsnano.5b03184 ↗
41. Size-dependent endocytosis of nanoparticles10.1002/adma.200801393 ↗
42. Macrophage recognition of crystals and nanoparticles10.3389/fimmu.2018.00103 ↗
43. Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK10.1152/ajplung.00058.2017 ↗
44. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting10.1021/acsnano.5b00147 ↗
45. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages10.3762/bjnano.5.174 ↗
46. The biologically effective dose in inhalation nanotoxicology10.1021/ar300092y ↗
47. Uptake of the proteins HTRA1 and HTRA2 by cells mediated by calcium phosphate nanoparticles10.3762/bjnano.8.40 ↗
48. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles10.1021/ja107583h ↗
49. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology10.1038/nnano.2013.181 ↗
50. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies10.1186/1743-8977-7-36 ↗
51. Assessment of orally dosed commercial silver nanoparticles on human ex vivo platelet aggregation10.3109/17435390.2013.788749 ↗
52. An integrated approach for the in vitro dosimetry of engineered nanomaterials10.1186/1743-8977-11-20 ↗
53. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays10.1093/toxsci/kfn072 ↗
54. An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials10.1186/s12951-016-0164-2 ↗
55. Triple-labeling of polymer-coated quantum dots and adsorbed proteins for tracing their fate in cell cultures10.1021/acsnano.9b00728 ↗
56. Reduction of nanoparticle load in cells by mitosis but not exocytosis10.1021/acsnano.9b01604 ↗
57. Endocytosis and exocytosis of nanoparticles in mammalian cells
58. The role of surface functionality in nanoparticle exocytosis10.1002/adhm.201400001 ↗
59. Internalization by HeLa cells of latex beads coated with mammalian cell entry (Mce) proteins encoded by the mce3 operon of Mycobacterium tuberculosis10.1099/jmm.0.47095-0 ↗
60. Cellular uptake of nanoparticles: journey inside the cell10.1039/C6CS00636A ↗
61. Phagocytosis is mediated by two-dimensional assemblies of the F-BAR protein GAS710.1038/s41467-019-12738-w ↗
62. The interplay of size and surface functionality on the cellular uptake of sub-10 nm gold nanoparticles10.1021/acsnano.5b03521 ↗
63. Mechanistic aspects of fluorescent gold nanocluster internalization by live HeLa cells10.1039/c2nr33147k ↗
64. Nanoparticle geometry and surface orientation influence mode of cellular uptake10.1021/nn304439f ↗
65. On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods10.1016/j.jconrel.2012.05.020 ↗
66. Endocytosis of nanomedicines10.1016/j.jconrel.2010.01.036 ↗
67. Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells10.1038/srep11371 ↗
68. Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms10.1016/j.biomaterials.2010.12.036 ↗
69. Controlled inhibition of the mesenchymal stromal cell pro-inflammatory secretome via microparticle engineering10.1016/j.stemcr.2016.05.003 ↗